Market Tracker

08/16 5:16pm ET

ImmuCell Corp (NASDAQ:ICCC)

6.60
Delayed Data
As of Aug 16
 -0.50 / -7.04%
Today’s Change
4.76
Today|||52-Week Range
8.24
+10.92%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.10
Today’s open7.05
Day’s range6.52 - 7.05
Volume11,926
Average volume (3 months)7,314
Market cap$35.8M
Dividend yield--
Data as of 3:59pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio55.0
Price/Sales2.70
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...-0.03-2.03%
APOPCellect Biotechnolog...-0.13-2.02%
AZRXAzurRx BioPharma Inc-0.04-1.05%
APVOAptevo Therapeutics ...0.000.00%
Data as of 3:59pm ET, 08/16/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts